UBS Reiterates Buy Rating on Abbott Labs (ABT): Modelling ~6% Dx growth TOT in 2026
Tweet Send to a Friend
UBS analyst Danielle Antalffy reiterated a Buy rating and $158.00 price target on Abbott Labs (NYSE: ABT).The analyst commented, "ABT ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
